2024-514013-34-00Not yet recruitingPhase 4
Unravelling the invisiBle infiltRating cOmponeNT Of glioblaStomA Using mRi USpio (BRONTOSAURUS)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To what extent, do GBMs infiltrate healthy brain tissue and can we use ultrasmall superparamagnetic iron oxide particles to visualize co-opting infiltrating tumor cells in an attempt to predict regions of tumor recurrence?
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 11 Nov 2024
- Start date
- 1 Jan 2025
- Lead sponsor
- Stichting Radboud universitair medisch centrum
- Diseases
- Glioblastoma
- EU CT number
- 2024-514013-34-00
- EudraCT number
- 2023-000068-80
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 15
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Who cannot take part
Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients unfit for surgery or lesions unsuitable for neurosurgical treatment
Age
- Younger than 18 years
Who the study is looking for
- Diagnosed with suspected glioblastoma
- Age between 18-75 years
- Eligible for neurosurgical resection and/or chemoradiation therapy.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Radboud universitair medisch centrum Stichting | Nijmegen | Netherlands | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.